After a decade of advocating research about the impact of lupus on military service, the Lupus Foundation of America recently announced the creation of a research program at the U.S. Defense Department, made possible by a $5 million endowment authorized by Congress this year.
Studies on the efficacy of Merck’s Keytruda medication on bladder, gastric and 10 other types of cancer will be presented at the European Society for Medical Oncology 2017 Congress through Sept. 12 in Madrid.
Tracking the body’s own immune response to ALS, also known as Lou Gehrig's disease, may give doctors new clues about the disease’s progression, according to a paper published in the July issue of the Journal of Neuroinflammation.
University of Illinois Hospital & Health Sciences System (UI Health) said it recently was named "Most Wired" health care organization for 2017 by Hospitals & Health Networks for using technology to improve operations.
Once skin cancer in advanced stages has been surgically removed, Opdivo may be the best option to keep the malignancy at bay, according to a Phase 3 clinical trial sponsored by manufacturer Bristol-Myers-Squibb.
Chemotherapy may save lives, but it can also cause patient hair loss – which is why pharmaceutical device maker Dignitana Inc. developed a special cap, recently FDA approved, to prevent this unpleasant side effect.
The results of two studies on the fertility drug Rekovelle showing the drug’s efficacy and safety during in vitro fertilization were presented at the European Society of Human Reproduction and Embryology’s 33rd annual meeting in Geneva, Switzerland.
Positive results from a Phase 3 clinical trial recently prompted the European Commission to approve Besponsa, Pfizer Inc.’s new immunotherapy treatment for patients suffering from B-cell precursor acute lymphoblastic leukemia, the pharmaceutical said in a release.
With the number of blood donations falling more than 60,000 short of demand during the last quarter, the American Red Cross is reminding all eligible donors that their participation may be a matter of life or death.
Children at risk of developing asthma saw a reduction or elimination of their symptoms when treated early with ALK’s Grazax asthma drug, according to results from a five-year clinical trial published in The Journal of Allergy and Clinical Immunology.
Researchers at Northwestern Medicine in Chicago, aided by $3.3 million in funding from the National Institutes of Health, have launched a clinical trial to unlock the secrets of a widely seen inherited heart defect known as bicuspid aortic valve (BAV).
A complication of open-heart surgery that keeps patients from absorbing essential protein through their intestinal walls has been solved, according to a study by scientists at Children’s Hospital of Philadelphia and Penn Medicine in Philadelphia.
Astellas said preliminary results from an ongoing clinical trial of its potential leukemia drug gilteritinib show it may be a long-awaited treatment option for certain patients with a acute myeloid leukemia.